Published in Diabetes Care on May 01, 2007
Clinical spectrum associated with hepatocyte nuclear factor-1beta mutations. Ann Intern Med (2004) 3.32
Effect of a diabetic environment in utero on predisposition to type 2 diabetes. Lancet (2003) 2.74
Optimizing nucleic acid extraction from thyroid fine-needle aspiration cells in stained slides, formalin-fixed/paraffin-embedded tissues, and long-term stored blood samples. Arq Bras Endocrinol Metabol (2012) 2.57
Mutations in potassium channel Kir2.6 cause susceptibility to thyrotoxic hypokalemic periodic paralysis. Cell (2010) 2.42
Subclinical hyperthyroidism and the risk of coronary heart disease and mortality. Arch Intern Med (2012) 2.24
Large genomic rearrangements in the hepatocyte nuclear factor-1beta (TCF2) gene are the most frequent cause of maturity-onset diabetes of the young type 5. Diabetes (2005) 1.79
The generation and utilization of a cancer-oriented representation of the human transcriptome by using expressed sequence tags. Proc Natl Acad Sci U S A (2003) 1.79
A mutation in the KCNE3 potassium channel gene is associated with susceptibility to thyrotoxic hypokalemic periodic paralysis. J Clin Endocrinol Metab (2002) 1.67
The type and the position of HNF1A mutation modulate age at diagnosis of diabetes in patients with maturity-onset diabetes of the young (MODY)-3. Diabetes (2007) 1.65
Screening for macroprolactinaemia and pituitary imaging studies. Clin Endocrinol (Oxf) (2002) 1.53
Impaired metabolic effects of a thyroid hormone receptor beta-selective agonist in a mouse model of diet-induced obesity. Thyroid (2010) 1.52
Expanding indications for recombinant human TSH in thyroid cancer. Thyroid (2008) 1.49
A preoperative diagnostic test that distinguishes benign from malignant thyroid carcinoma based on gene expression. J Clin Invest (2004) 1.48
Subclinical thyroid dysfunctions are independent risk factors for mortality in a 7.5-year follow-up: the Japanese-Brazilian thyroid study. Eur J Endocrinol (2009) 1.47
[Tolerance of the oral clonidine test in 180 patients: efficacy of the volemic expantion in controlling arterial hypotension]. Arq Bras Endocrinol Metabol (2005) 1.42
[Unexpected high values of TSH: the presence of high molecular weight forms (macro TSH) must be investigated]. Arq Bras Endocrinol Metabol (2006) 1.40
[Parathyroid carcinoma]. Arq Bras Endocrinol Metabol (2006) 1.39
Glucose tolerance and insulin secretion, morbidity, and death in patients with cystic fibrosis. J Pediatr (2007) 1.34
Paracrine signaling by glial cell-derived triiodothyronine activates neuronal gene expression in the rodent brain and human cells. J Clin Invest (2010) 1.29
Long-term follow-up of oral glucose tolerance test-derived glucose tolerance and insulin secretion and insulin sensitivity indexes in subjects with glucokinase mutations (MODY2). Diabetes Care (2008) 1.12
[Thyrotoxic hypokalemic periodic paralysis, an endocrine emergency: clinical and genetic features in 25 patients]. Arq Bras Endocrinol Metabol (2004) 1.07
Diagnosis of suspicious thyroid nodules using four protein biomarkers. Clin Cancer Res (2006) 1.07
Influence of ultraviolet radiation on the production of 25 hydroxyvitamin D in the elderly population in the city of São Paulo (23 degrees 34'S), Brazil. Osteoporos Int (2005) 1.05
Glucose metabolism in 105 children and adolescents after pancreatectomy for congenital hyperinsulinism. Diabetes Care (2011) 1.04
The N363S polymorphism in the glucocorticoid receptor gene is associated with overweight in subjects with type 2 diabetes mellitus. Clin Endocrinol (Oxf) (2003) 1.01
Thyroid nodules and differentiated thyroid cancer: update on the Brazilian consensus. Arq Bras Endocrinol Metabol (2013) 1.00
The common -866G>A variant in the promoter of UCP2 is associated with decreased risk of coronary artery disease in type 2 diabetic men. Diabetes (2008) 0.96
Practical determination of hyaluronan by a new noncompetitive fluorescence-based assay on serum of normal and cirrhotic patients. Anal Biochem (2003) 0.95
Genetic and clinical characteristics of maturity-onset diabetes of the young. Diabetes Obes Metab (2005) 0.94
Early diagnosis of multiple endocrine neoplasia type 2B: a challenge for physicians. Arq Bras Endocrinol Metabol (2008) 0.93
Development of a sensitive and specific quantitative reverse transcription-polymerase chain reaction assay for blood thyroglobulin messenger ribonucleic acid in the follow-up of patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab (2010) 0.92
Parity is not related to autoimmune thyroid disease in a population-based study of Japanese-Brazilians. Thyroid (2010) 0.91
A novel germ-line point mutation in RET exon 8 (Gly(533)Cys) in a large kindred with familial medullary thyroid carcinoma. J Clin Endocrinol Metab (2003) 0.91
[Prevalence of vitamin D deficiency, insufficiency and secondary hyperparathyroidism in the elderly inpatients and living in the community of the city of São Paulo, Brazil]. Arq Bras Endocrinol Metabol (2007) 0.91
Normal perioperative serum calcitonin levels in patients with advanced medullary thyroid carcinoma: case report and review of the literature. Thyroid (2008) 0.90
Clinical and molecular analysis of thyroid hypoplasia: a population-based approach in southern Brazil. Thyroid (2009) 0.90
Plasma extracellular superoxide dismutase concentration, allelic variations in the SOD3 gene and risk of myocardial infarction and all-cause mortality in people with type 1 and type 2 diabetes. Cardiovasc Diabetol (2015) 0.90
Insulin autoimmune syndrome (Hirata disease) as differential diagnosis in patients with hyperinsulinemic hypoglycemia. Pancreas (2006) 0.89
[Thyroid nodules and differentiated thyroid cancer: Brazilian consensus]. Arq Bras Endocrinol Metabol (2007) 0.89
Distribution of HOMA-IR in Brazilian subjects with different body mass indexes. Arq Bras Endocrinol Metabol (2006) 0.89
Association of serum concentration of TNFR1 with all-cause mortality in patients with type 2 diabetes and chronic kidney disease: follow-up of the SURDIAGENE Cohort. Diabetes Care (2014) 0.88
Two novel mutations in the EIF2AK3 gene in children with Wolcott-Rallison syndrome. Pediatr Diabetes (2010) 0.87
Diagnosis and management of maturity-onset diabetes of the young. Treat Endocrinol (2005) 0.87
[Usefulness of intraoperative PTH measurement in primary and secondary hyperparathyroidism: experience with 109 patients]. Arq Bras Endocrinol Metabol (2006) 0.87
Visfatin, glucose metabolism and vascular disease: a review of evidence. Diabetol Metab Syndr (2010) 0.87
The RET p.G533C mutation confers predisposition to multiple endocrine neoplasia type 2A in a Brazilian kindred and is able to induce a malignant phenotype in vitro and in vivo. Thyroid (2011) 0.87
Low prevalence of MODY2 and MODY3 mutations in Brazilian individuals with clinical MODY phenotype. Diabetes Res Clin Pract (2008) 0.87
Comparison between copeptin and vasopressin in a population from the community and in people with chronic kidney disease. J Clin Endocrinol Metab (2014) 0.85
Identification of candidates for tumor-specific alternative splicing in the thyroid. Genes Chromosomes Cancer (2006) 0.85
Plasma Copeptin and Decline in Renal Function in a Cohort from the Community: The Prospective D.E.S.I.R. Study. Am J Nephrol (2015) 0.85
Dipeptidyl peptidase IV inhibition upregulates GLUT4 translocation and expression in heart and skeletal muscle of spontaneously hypertensive rats. Eur J Pharmacol (2012) 0.85
A polymorphism in the promoter of UCP2 gene modulates lipid levels in patients with type 2 diabetes. Mol Genet Metab (2004) 0.85
Proposed involvement of adipocyte glyceroneogenesis and phosphoenolpyruvate carboxykinase in the metabolic syndrome. Biochimie (2005) 0.85
Allelic variations in superoxide dismutase-1 (SOD1) gene and renal and cardiovascular morbidity and mortality in type 2 diabetic subjects. Mol Genet Metab (2012) 0.84
Fine needle aspiration and medullary thyroid carcinoma: the risk of inadequate preoperative evaluation and initial surgery when relying upon FNAB cytology alone. Endocr Pract (2013) 0.83
Association of ADIPOQ variants, total and high molecular weight adiponectin levels with coronary artery disease in diabetic and non-diabetic Brazilian subjects. J Diabetes Complications (2012) 0.83
Glibenclamide unresponsiveness in a Brazilian child with permanent neonatal diabetes mellitus and DEND syndrome due to a C166Y mutation in KCNJ11 (Kir6.2) gene. Arq Bras Endocrinol Metabol (2008) 0.83
Evaluation of RET polymorphisms in a six-generation family with G533C RET mutation: specific RET variants may modulate age at onset and clinical presentation. Clin Endocrinol (Oxf) (2008) 0.83
[Usefulness of neck ultrasonography in the follow-up of patients with differentiated thyroid cancer]. Arq Bras Endocrinol Metabol (2007) 0.83
Bone turnover assessment: a good surrogate marker? Arq Bras Endocrinol Metabol (2010) 0.83
Thyroid antibody status, subclinical hypothyroidism, and the risk of coronary heart disease: an individual participant data analysis. J Clin Endocrinol Metab (2014) 0.82
Cushing's disease as the first clinical manifestation of multiple endocrine neoplasia type 1 (MEN1) associated with an R460X mutation of the MEN1 gene. Clin Endocrinol (Oxf) (2004) 0.82
Association of circulating levels of nicotinamide phosphoribosyltransferase (NAMPT/Visfatin) and of a frequent polymorphism in the promoter of the NAMPT gene with coronary artery disease in diabetic and non-diabetic subjects. Cardiovasc Diabetol (2013) 0.82
The lactase persistence genotype is associated with body mass index and dairy consumption in the D.E.S.I.R. study. Metabolism (2013) 0.82
Allelic variations in superoxide dismutase-1 (SOD1) gene are associated with increased risk of diabetic nephropathy in type 1 diabetic subjects. Mol Genet Metab (2011) 0.82
The effectiveness of a non-pharmacological intervention for weight gain management in severe mental disorders: results from a national multicentric study. Rev Bras Psiquiatr (2011) 0.81
[Development of a semi-automated method for measuring urinary iodine and its application in epidemiological studies in Brazilian schoolchildren]. Arq Bras Endocrinol Metabol (2007) 0.81
HNF1alpha mutations are present in half of clinically defined MODY patients in South-Brazilian individuals. Arq Bras Endocrinol Metabol (2008) 0.81
Relationship between GH response and glycemic fluctuations in the glucagon stimulation test. Growth Horm IGF Res (2008) 0.81
Open-flap versus flapless esthetic crown lengthening: 12-month clinical outcomes of a randomized controlled clinical trial. J Periodontol (2013) 0.80
Influence of the polymorphisms Tpr64Arg in the beta 3-adrenergic receptor gene and Pro12Ala in the PPAR gamma 2 gene on metabolic syndrome-related phenotypes in an indigenous population of the Brazilian Amazon. Diabetes Care (2004) 0.80
Measurement of calcitonin and calcitonin gene-related peptide mRNA refines the management of patients with medullary thyroid cancer and may replace calcitonin-stimulation tests. Thyroid (2013) 0.80
Expression of phosphoenolpyruvate carboxykinase gene in human adipose tissue: induction by rosiglitazone and genetic analyses of the adipocyte-specific region of the promoter in type 2 diabetes. Biochimie (2003) 0.80
Ion channelopathies in endocrinology: recent genetic findings and pathophysiological insights. Arq Bras Endocrinol Metabol (2010) 0.80
Estimation of diabetes risk in Brazilian population by typing for polymorphisms in HLA-DR-DQ, INS and CTLA-4 genes. Dis Markers (2005) 0.80
A 6-month randomized controlled trial to test the efficacy of a lifestyle intervention for weight gain management in schizophrenia. BMC Psychiatry (2013) 0.80
The expression of PAX8-PPARgamma rearrangements is not specific to follicular thyroid carcinoma. Clin Endocrinol (Oxf) (2004) 0.80
Genetic variability at the six transmembrane protein of prostate 2 locus and the metabolic syndrome: the data from an epidemiological study on the Insulin Resistance Syndrome (DESIR) study. J Clin Endocrinol Metab (2010) 0.80